Take a comprehensive view of the whole text, how mitophagy is regulated by DRP-1 under pathologic status is critical and complex, which may contribute to the development of specific therapeutic interventions in cardiovascular diseases patients, for example Masatinib, the inhibitor of PDGFRβ. Here, DNM1L is linked to cardiovascular disorder.